These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 3000906

  • 1. [Analysis of Epstein-Barr virus transformation of human lymphocytes: susceptibility of B lymphocyte subpopulations and differentiation stage of the transformed cells].
    Koizumi S.
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):724-34. PubMed ID: 3000906
    [Abstract] [Full Text] [Related]

  • 2. Heterogeneity of EBV-transformable human B lymphocyte populations.
    Chan MA, Stein LD, Dosch HM, Sigal NH.
    J Immunol; 1986 Jan; 136(1):106-12. PubMed ID: 2999241
    [Abstract] [Full Text] [Related]

  • 3. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
    Hibi T, Chan MA, Petsche D, Dosch HM.
    J Immunol; 1986 May 01; 136(9):3211-8. PubMed ID: 3007613
    [Abstract] [Full Text] [Related]

  • 4. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
    Tosato G, Blaese RM, Yarchoan R.
    J Immunol; 1985 Aug 01; 135(2):959-64. PubMed ID: 2989369
    [Abstract] [Full Text] [Related]

  • 5. Surface marker characterization of EBV target cells in normal blood and tonsil B lymphocyte populations.
    Aman P, Gordon J, Lewin N, Nordström M, Ehlin-Henriksson B, Klein G, Carstensson A.
    J Immunol; 1985 Oct 01; 135(4):2362-7. PubMed ID: 2993411
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.
    Brown NA, Miller G.
    J Immunol; 1982 Jan 01; 128(1):24-9. PubMed ID: 6274955
    [Abstract] [Full Text] [Related]

  • 7. Binding of monoclonal antibody to the Epstein Barr virus (EBV)/CR2 receptor induces activation and differentiation of human B lymphocytes.
    Nemerow GR, McNaughton ME, Cooper NR.
    J Immunol; 1985 Nov 01; 135(5):3068-73. PubMed ID: 2995485
    [Abstract] [Full Text] [Related]

  • 8. Ig isotypes produced by EBV-transformed B cells as a function of age and tissue distribution.
    Miyawaki T, Kubagawa H, Butler JL, Cooper MD.
    J Immunol; 1988 Jun 01; 140(11):3887-92. PubMed ID: 2836502
    [Abstract] [Full Text] [Related]

  • 9. Synergy between anti-CD40 MAb and Epstein-Barr virus in activation and transformation of human B lymphocytes.
    Tsuchiyama L, Kieran J, Boyle P, Wetzel GD.
    Hum Antibodies; 1997 Jun 01; 8(1):43-7. PubMed ID: 9265505
    [Abstract] [Full Text] [Related]

  • 10. Changes in the phenotype and immunoglobulin secretion of human B cells following co-culture with cells of an EBV+ lymphoblastoid line or fusion with mouse plasmacytoma cells. Studies in short-term and long-term culture.
    Ling NR, Lowe JA.
    Clin Exp Immunol; 1989 Feb 01; 75(2):311-6. PubMed ID: 2539279
    [Abstract] [Full Text] [Related]

  • 11. Isotype commitment of human B cells that are transformed by Epstein-Barr virus.
    Miyawaki T, Butler JL, Radbruch A, Gartland GL, Cooper MD.
    Eur J Immunol; 1991 Jan 01; 21(1):215-20. PubMed ID: 1846818
    [Abstract] [Full Text] [Related]

  • 12. B-cell maturation stages of Burkitt's lymphoma cell lines according to Epstein-Barr virus status and type of chromosome translocation.
    Cohen JH, Revillard JP, Magaud JP, Lenoir G, Vuillaume M, Manel AM, Vincent C, Bryon PA.
    J Natl Cancer Inst; 1987 Feb 01; 78(2):235-42. PubMed ID: 3027441
    [Abstract] [Full Text] [Related]

  • 13. Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.
    Golay JT, Crawford DH.
    Immunology; 1987 Oct 01; 62(2):279-84. PubMed ID: 2824347
    [Abstract] [Full Text] [Related]

  • 14. Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis.
    Kuwano K, Arai S, Munakata T, Tomita Y, Yoshitake Y, Kumagai K.
    J Immunol; 1986 Sep 01; 137(5):1462-8. PubMed ID: 3018077
    [Abstract] [Full Text] [Related]

  • 15. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S.
    Med Biol; 1982 Oct 01; 60(5):255-9. PubMed ID: 6296556
    [Abstract] [Full Text] [Related]

  • 16. Limiting dilution analysis of the B cell compartment in human bone marrow.
    Hibi T, Dosch HM.
    Eur J Immunol; 1986 Feb 01; 16(2):139-45. PubMed ID: 2869953
    [Abstract] [Full Text] [Related]

  • 17. In vitro regulation of IgA subclass production. III. Selective transformation of IgA1 producing cells by Epstein-Barr virus.
    Conley ME, Chan MA, Sigal NH.
    J Immunol; 1987 Mar 01; 138(5):1403-7. PubMed ID: 3027178
    [Abstract] [Full Text] [Related]

  • 18. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
    Yokochi T, Holly RD, Clark EA.
    J Immunol; 1982 Feb 01; 128(2):823-7. PubMed ID: 6274961
    [Abstract] [Full Text] [Related]

  • 19. Transformation of human colostrum lymphocytes with Epstein-Barr virus and the production of IgA in culture.
    Maeda-Takekoshi F, Takekoshi M, Tanaka S, Watanabe Y, Dosako S, Kikuchi E.
    Tokai J Exp Clin Med; 1984 Jun 01; 9(2):103-8. PubMed ID: 6100146
    [Abstract] [Full Text] [Related]

  • 20. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS, Park GB, Choi YM, Kwon OS, Song HK, Kang JS, Kim YI, Lee WJ, Hur DY.
    Hum Immunol; 2006 Oct 01; 67(10):795-807. PubMed ID: 17055356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.